Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ellis

Showing results (971-980 of 1,150) with videos related to

Pageof 115
Sort By:
Circulation|October 1, 1994
Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplastyJ E Tcheng, S G Ellis, B S George, et al.
Circulation|July 1, 1997
End-systolic volume index at 90 to 180 minutes into reperfusion therapy for acute myocardial infarction is a strong predictor of early and late mortality. The Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I Angiographic InvestigatorsR Q Migrino, J B Young, S G Ellis, et al.
The American Journal of Cardiology|October 29, 2005
Impact of coronary culprit lesion calcium in patients undergoing paclitaxel-eluting stent implantation (a TAXUS-IV sub study)Issam Moussa, Stephen G Ellis, Michael Jones, et al.
Journal of the American College of Cardiology|October 1, 1989
Combined tissue-type plasminogen activator and prostacyclin therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 4 Study GroupE J Topol, S G Ellis, R M Califf, et al.
JAMA|March 15, 2006
Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trialGregg W Stone, Stephen G Ellis, Charles D O'Shaughnessy, et al.
The American Journal of Cardiology|March 1, 1993
Quantitative analysis of factors influencing late lumen loss and restenosis after directional coronary atherectomyJ J Popma, N B De Cesare, C A Pinkerton, et al.
The New England Journal of Medicine|January 16, 2004
A polymer-based, paclitaxel-eluting stent in patients with coronary artery diseaseGregg W Stone, Stephen G Ellis, David A Cox, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 15, 2012
Long term follow-up of drug eluting versus bare metal stents in the treatment of saphenous vein graft lesionsLuiz F Ybarra, Henrique B Ribeiro, Antonio H Pozetti, et al.
Circulation|August 1, 1991
Relation of stenosis morphology and clinical presentation to the procedural results of directional coronary atherectomyS G Ellis, N B De Cesare, C A Pinkerton, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 9, 2021
Optimal dual antiplatelet therapy duration for bioresorbable scaffolds: an individual patient data pooled analysis of the ABSORB trialsLorenzo Azzalini, Stephen G Ellis, Dean J Kereiakes, et al.
Pageof 115

Showing results (971-980 of 1,150) with videos related to

Sort By:
Pageof 115
Circulation|October 1, 1994
Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplastyJ E Tcheng, S G Ellis, B S George, et al.
Circulation|July 1, 1997
End-systolic volume index at 90 to 180 minutes into reperfusion therapy for acute myocardial infarction is a strong predictor of early and late mortality. The Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I Angiographic InvestigatorsR Q Migrino, J B Young, S G Ellis, et al.
The American Journal of Cardiology|October 29, 2005
Impact of coronary culprit lesion calcium in patients undergoing paclitaxel-eluting stent implantation (a TAXUS-IV sub study)Issam Moussa, Stephen G Ellis, Michael Jones, et al.
Journal of the American College of Cardiology|October 1, 1989
Combined tissue-type plasminogen activator and prostacyclin therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 4 Study GroupE J Topol, S G Ellis, R M Califf, et al.
JAMA|March 15, 2006
Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trialGregg W Stone, Stephen G Ellis, Charles D O'Shaughnessy, et al.
The American Journal of Cardiology|March 1, 1993
Quantitative analysis of factors influencing late lumen loss and restenosis after directional coronary atherectomyJ J Popma, N B De Cesare, C A Pinkerton, et al.
The New England Journal of Medicine|January 16, 2004
A polymer-based, paclitaxel-eluting stent in patients with coronary artery diseaseGregg W Stone, Stephen G Ellis, David A Cox, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 15, 2012
Long term follow-up of drug eluting versus bare metal stents in the treatment of saphenous vein graft lesionsLuiz F Ybarra, Henrique B Ribeiro, Antonio H Pozetti, et al.
Circulation|August 1, 1991
Relation of stenosis morphology and clinical presentation to the procedural results of directional coronary atherectomyS G Ellis, N B De Cesare, C A Pinkerton, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 9, 2021
Optimal dual antiplatelet therapy duration for bioresorbable scaffolds: an individual patient data pooled analysis of the ABSORB trialsLorenzo Azzalini, Stephen G Ellis, Dean J Kereiakes, et al.
Pageof 115